DEVELOPING | Montreal organized crime figure Francesco Del Balso killed in daylight shooting

A 22-year-old McGill student who suffers from a terminal disease could soon lose access to the medication she needs because she's graduating from university.
Amanda Tam said a year and a half ago – five days before her 21st birthday – she felt something strange going on with her body.
"A lot of twitching, grip strength was very strange, very weak. Doing exercise was very hard," she said,
She was diagnosed with amyotrophic lateral sclerosis, or ALS, four months later.
The progressive neurological disease has a median survival rate of just three years.
The perennially positive young woman has shared her story on TikTok, with some posts that have been viewed tens of thousands of times. They're her way of raising awareness about ALS.
One reason she's remained so upbeat is a new drug called Albrioza, which has been slowing the progression of Tam's ALS.
"Albrioza was just approved a few months ago by Health Canada, and luckily for me, I was able to access it earlier than others because I have private insurance," she said.
Albrioza has been a game changer, said Tam's doctor, Angela Genge, director of the ALS program at the Montreal Neurology Clinic.
"In a disease like ALS, which is relentlessly progressive, when you have a drug that halts or slows down that progression, it means that people like Amanda can stay independent and start planning their futures," she said.
Tam can be covered by her parents' health insurance as long as she is a student.
But in two months, she's graduating, meaning Tam will lose her coverage. Her prescription for Albrioza will cost her $94,000 per year, which Quebec's public health and drug insurance plan does not cover.
"People who are desperate for this medication just to live a bit longer, they should have the right to have access to it," said Genge.
Tam doesn't have the time to wait for governments, and just wants to live her life like other young people.
"Obviously, I want to have that experience that every young 20-year-old has, struggling to pay rent, living day to day, trying to learn how to cook, do laundry," she said.
Tam's doctor has spent time calling the health ministry, but she remains baffled that nothing has changed.
"They allow every cancer patient to have access to whatever drug is approved and available," she said. "It's time to do the same for ALS."
The federal prison service says it will have a second look at its decision to move convicted killer Paul Bernardo to a medium-security facility as political leaders of all stripes react to the news with shock and outrage.
Wildfire smoke prompted warnings about poor air quality for many regions across the country, stretching from northern Alberta to the Atlantic.
Conservative Leader Pierre Poilievre is threatening to use procedural tools to delay passage of the federal budget in the House of Commons if the Liberals don't meet his demands.
The Canadian Medical Association and 14 other organizations representing health workers are urging premiers to keep health care at the top of the agenda at their next meeting in July.
Princess Eugenie has given birth to a baby boy, Buckingham Palace announced Monday.
Canadians are continuing to spend more money on travel as the industry rebounds slowly from pandemic disruptions, according to a recent report — but many are opting for closer destinations, with travel to the U.S. on the rise.
A whiskey brand co-founded by actor Kiefer Sutherland says it has raised more than $100,000 for relief efforts related to the ongoing Nova Scotia wildfires.
The federal government will be providing $1.5 million to Pride organizations across the country for increased security measures at parades and other events this year, CTV News has learned.
Prince Harry's phone hacking trial against the publisher of the Daily Mirror kicked off Monday without him present -- and the judge was not happy.